Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HPK | KOS |
|---|---|---|
| Price | $8.52 | $2.59 |
| Change today | ▲ 3.65% | ▼ 0.38% |
| Market cap | $1.08B | $1.54B |
| Return, 3 months | +21.7% | +18.8% |
| Return, year to date | +79.7% | +184.6% |
| Return, 1 year | +21.6% | +48.0% |
| P/E (TTM) | -12.5 | -2.3 |
| P/B | 0.7 | 2.2 |
| P/E percentile vs own 5y | 0th | 25th |
| Dividend yield | 0.94% | – |
| Revenue growth (YoY, latest qtr) | +25.8% | +54.7% |
| Net profit growth (YoY) | +214.3% | +310.6% |
| Gross margin | 21.5% | 28.4% |
| Operating margin | 15.7% | 9.2% |
| Net margin | -9.8% | -34.2% |
| Return on equity | -5.3% | -63.0% |
| Analyst target vs. price | +17.4% | -9.7% |
| Analyst buy share | 100% | 25% |
| RSI (14) | 59 | 46 |
| 30-day volatility | 49.3% | 52.1% |
| Max drawdown, 1 year | -46.7% | -53.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
